Therapeutic Drug Monitoring of Infliximab in Jordanian Patients
Abstract
Keywords
Supporting Institution
Project Number
Ethical Statement
Thanks
References
- Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: A review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018; 15: 39-49. https://doi.org/10.1038/nrgastro.2017.136
- Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis. Nat Rev Dis Primers. 2020; 6: 74. https://doi.org/10.1038/s41572-020-0205-x
- Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017; 389(10080): 1741-1755. https://doi.org/10.1016/S0140-6736(16)31711-1
- Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018; 16(1): 26-42. https://doi.org/10.5217/ir.2018.16.1.26
- Hossain M, Lordal AE, Olsson A, Storlahls S, Aleman M, Eberhardson R, Befrits S. Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance Infliximab treatment in inflammatory bowel disease. Scand J Gastroenterol. 2020; 55: 178-183. https://doi.org/10.1080/00365521.2020.1722738
- Xue JC, Hou XT, Zhao YW, Yuan S. Biological agents as attractive targets for inflammatory bowel disease therapeutics. Biochim Biophys Acta Mol Basis Dis. 2025; 1871(3): 167648. https://doi.org/10.1016/j.bbadis.2024.167648.
- Ben-Horin S, Chowers Y. Review article: loss of response to anti-TNF treatments in Crohn's disease. Aliment Pharmacol Ther. 2011; 33(9): 987-995. https://doi.org/10.1111/j.1365-2036.2011.04612.x
- Wong U, Cross RK. Primary and secondary nonresponse to Infliximab: mechanisms and countermeasures. Expert Opin Drug Metab Toxicol. 2017; 13(10): 1039-1046. https://doi.org/10.1080/17425255.2017.1377180
Details
Primary Language
English
Subjects
Clinical Pharmacology and Therapeutics
Journal Section
Research Article
Authors
Salim Hamadi
0000-0003-2534-7900
Jordan
Hanaa Khalaf
0009-0000-0295-069X
Jordan
Haya Tuffaha
0009-0008-5235-5272
Jordan
Mohammad Quta
0009-0004-3408-0966
Jordan
Aya Tarawneh
0009-0004-7608-1182
Jordan
Asmaa Zinati
0009-0009-1111-375X
Jordan
Moyad Qudah
0009-0004-1577-5631
Jordan
Motaz Jibril
0009-0004-0635-3023
Jordan
Ahmad Ayesh
0009-0002-9899-6231
Jordan
Aseel Aljhani
0009-0006-3187-452X
Jordan
Maisa Matahen
0009-0006-0719-0371
Jordan
Publication Date
November 12, 2026
Submission Date
March 26, 2026
Acceptance Date
October 18, 2026
Published in Issue
Year 2026 Volume: 30 Number: 6